Medicare Extends Telehealth Provisions Until 2027: Impact on Behavioral Health

Medicare's extension of telehealth provisions until 2027 ensures continued reimbursement for virtual care services, providing a stable framework for beneficiaries who prefer remote consultations. Since 2021, Medicare has made telehealth arrangements for behavioral and mental health permanent, removing previous restrictions on geographic locations and originating sites, thus elevating virtual behavioral health services within Medicare.

Additionally, the Drug Enforcement Administration (DEA) has extended its telemedicine flexibilities until 2026, permitting healthcare providers to prescribe certain controlled substances without in-person consultation. This is particularly significant for maintaining access to behavioral healthcare, especially in underserved areas.

While these federal measures offer short-term assurance, they are not permanent. Healthcare providers continue to lobby Congress for long-term measures to maintain care delivery consistency. Shannon Werb, CEO of Array Behavioral Care, highlights that these measures offer operational certainty. "Providers can invest in telehealth infrastructure, personnel, and clinical workflows with the assurance of continued reimbursement and prescribing flexibility," Werb stated.

Werb emphasized that these extensions facilitate deeper integration of telehealth across healthcare service lines, including behavioral health and specialty consultations. Telehealth helps organizations manage clinician shortages, expand specialty service access, and alleviate pressure on in-person healthcare teams, enabling a shift from makeshift solutions to sustainable hybrid care models.

The policy adjustments also allow providers to evolve their use of telehealth technologies. As virtual care becomes ingrained in routine operations, providers are assessed based on care quality and clinical integration. In behavioral health, this evolution illustrates telehealth's scalability and effectiveness while maintaining consistent access.

Werb predicts that private payers will continue to align with Medicare's telehealth policies. "Significant changes in private payer practices are unlikely in the short term," Werb noted. "Most have aligned with Medicare's telehealth approach, particularly in behavioral health." The Medicare extensions reaffirm the course private payers have taken toward more stable coverage policies.

The extensions in prescribing capabilities encourage private payers to enhance clinician participation and adopt comprehensive virtual care models. Over time, this could lead to telehealth being fully integrated into behavioral health services. "Hybrid care is becoming the norm across various specialties," Werb stated, emphasizing the strategic use of both virtual and in-person care based on clinical and patient needs, rather than regulatory limitations.